Corpus 1,272 assessed · 1,173 scored · 643 reproduced ≥75 · 168 flagged ·∅ 74.1/100

Publications 3 Datasets 392.5k Experiments 4.7k

Explore

Filters: Lung ✕ bulk-rna-seq ✕ clear all

3 matching publication(s)

Publication	Journal	Year	Score	Verdict
COVID-19 lung disease shares driver AT2 cytopathic features with Idiopathic pulmonary fibrosis. PMID 35870428	EBioMedicine	2022	85	L1 85/100
In vivo induction of activin A-producing alveolar macrophages supports the progression of lung cell carcinoma. PMID 36650150	Nat Commun	2023	96	L1 96/100
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2. PMID 32333836	Cell	2020	87	L1 87/100

COVID-19 lung disease shares driver AT2 cytopathic features with Idiopathic pulmonary fibrosis.

PMID 35870428 · EBioMedicine · 2022

L1 85/100

In vivo induction of activin A-producing alveolar macrophages supports the progression of lung cell carcinoma.

PMID 36650150 · Nat Commun · 2023

L1 96/100

Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2.

PMID 32333836 · Cell · 2020

L1 87/100